Note! Generated by AI. I asked myself and got nearly the same answer. Still, it really does seem good.
I am very puzzled by Revenioâs valuation. The multiples of this former growth company have been pushed down to value stock levels. The market no longer believes the company will return to any kind of growth. There is zero confidence in new acquisitions; it is believed they will only destroy value. What stands out most is the balance sheet-based valuation. The P/B for this year is only 1.8x. Multiples like these havenât been seen since the ârubber boat days.â However, the company is still generating decent profits, even if new acquisitions will dilute margins. In my opinion, the company still belongs among the quality stocks on the Helsinki Stock Exchange, with clear competitive advantages.
I bought the stock for my portfolio today at âŹ13.40.
35 Likes
It took a moment to figure out. There was an extra zero there. It was confusing, as the same error was found elsewhere too. So, it is the IC100 in question.
Take another look further down the page. The IC100 was approved 10 years ago already.
1 Like
A bit of speculation, but perhaps the USA has been requesting additional studies one after another. Even though the model isnât specified, my spider sense says itâs the same device.
Just put the devices on sale without the USA and get money into the bank.
Could it be an entirely different device, since the identifier is also different from the IC1000?
That seems to be the case. Itâs strange that there is so little information available. Nothing really from the manufacturer. Could it be some kind of breakthrough product that has been long-awaitedâŠ
Quite a few new patents this year.
E.g.
WO2026057923A1 â Air pulse tonometers â published March 19, 2026
WO2026047277A1 â An air pulse based tonometer â published March 5, 2026
Could this be related to that TA05 device?